Skip to main content

Table 3 Inter-observer agreement for decision tree chance nodes

From: The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre

Decision tree chance node measurement

Kappa

95% CI

Supraclavicular lymphadenopathy

1.00

1.00–1.00

Radial EBUS accessible

0.291

0.163–0.420

Distant metastatic disease on FDG-PET/CT

0.661

0.428–0.895

Accessible metastatic disease

0.696

0.415–0.977

Hilar FDG-PET positive lymph nodes

0.626

0.469–0.783

HAL full model

0.873

0.821–0.910